111 Other Long-Term Assets 2018-2024 | YI

111 other long-term assets from 2018 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
111 Annual Other Long-Term Assets
(Millions of US $)
2024 $2
2023 $2
2022 $3
2021 $3
2020 $1
2019 $0
2018 $0
2017 $0
111 Quarterly Other Long-Term Assets
(Millions of US $)
2024-12-31 $2
2024-09-30 $2
2024-06-30 $2
2024-03-31 $2
2023-12-31 $2
2023-09-30 $2
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $4
2021-12-31 $3
2021-09-30 $4
2021-06-30 $4
2021-03-31 $2
2020-12-31 $1
2020-09-30 $1
2020-06-30 $0
2020-03-31 $1
2019-12-31 $0
2019-09-30 $1
2019-06-30 $0
2019-03-31 $1
2018-09-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.068B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.151B 48.75
Hims & Hers Health (HIMS) United States $11.939B 124.05
Tempus AI (TEM) United States $9.210B 0.00
IRhythm Technologies (IRTC) United States $4.513B 0.00
Inspire Medical Systems (INSP) United States $4.137B 64.64
Privia Health (PRVA) United States $2.813B 192.25
Enovis (ENOV) United States $1.861B 10.37
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.579B 0.00
Phreesia (PHR) United States $1.385B 0.00
Omnicell (OMCL) United States $1.376B 24.27
Azenta (AZTA) United States $1.241B 57.66
10x Genomics (TXG) United States $1.091B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.626B 0.00
Talkspace (TALK) United States $0.495B 148.00
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.438B 0.00
Standard BioTools (LAB) United States $0.414B 0.00
TruBridge (TBRG) United States $0.358B 793.33
Outset Medical (OM) United States $0.346B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.256B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.132B 0.00
Pulmonx (LUNG) United States $0.119B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.31
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00